| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 07/04/2006 | US7071221 Heterocyclic oxime compounds |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071178 Bone disorders; osteoporosis |
| 07/04/2006 | US7071166 Healing promoters for skin wounds such as rupture, abrasion, surgical incision, skin ulcer and burn. Coexistence of Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu- Met-NH2 or Phe-Gly-Leu-Met-NH2 with insulin-like growth factor-I as |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | CA2404848C Indole carboxylic acids as thyroid receptor ligands |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006068254A1 Skin-whitening agent |
| 06/29/2006 | WO2006068212A1 Lipase inhibitor and preventive/remedy for skin diseases |
| 06/29/2006 | WO2006068058A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | WO2006067985A1 Novel polyphenol glycoside derived from acerola |
| 06/29/2006 | WO2006067945A1 External skin agent comprising modified clay for preventing inflammation |
| 06/29/2006 | WO2006067920A1 Pharmaceutical for bone marrow stem cell transplantation therapy |
| 06/29/2006 | WO2006067549A1 Hemostatic composition, apparatus, and methods |
| 06/29/2006 | WO2006066987A1 Anti-radical agents |
| 06/29/2006 | WO2006066978A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics |
| 06/29/2006 | WO2006066846A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 06/29/2006 | WO2006066323A1 Formulations and treatments for trichology |
| 06/29/2006 | WO2006057886A3 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/29/2006 | WO2006057885A3 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/29/2006 | WO2006053791A3 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/29/2006 | WO2006015079A3 Erm family binding agents and their use in diagnosis and treatment of proliferative conditions |
| 06/29/2006 | US20060142382 Skin lightening composition |
| 06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142330 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's and attention deficit disorder, schizophrenia, obsessive compulsive disorders, |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060142236 Antisense oligonucleotide modulation of raf gene expression |
| 06/29/2006 | US20060142235 Method of reducing and treating UVB-induced immunosuppression |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140905 Chemokine beta-7 variants |
| 06/29/2006 | US20060140872 Novel signaling pathway for the production of inglammatory pain and neuropathy |
| 06/29/2006 | DE102004061288A1 New 3-amino-pyrazolo(3,4b)pyridine derivatives are protein tyrosine kinases inhibitors useful e.g. for treating hyperproliferation of body cells, neurodegenerative disease, blood vessel disease and angiogenic disease |
| 06/29/2006 | CA2592068A1 External skin agent comprising modified clay for preventing inflammation |
| 06/29/2006 | CA2592004A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 06/29/2006 | CA2591813A1 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 06/29/2006 | CA2591757A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | CA2591083A1 Medicaments for the treatment or prevention of fibrotic diseases |
| 06/29/2006 | CA2590246A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics |
| 06/29/2006 | CA2589667A1 Vitamin d receptor modulators |
| 06/28/2006 | EP1674456A2 Substituted alpha-halo-beta-keto-pyridinylpropanoates |
| 06/28/2006 | EP1674454A1 SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674095A1 Phototherapy compositions |
| 06/28/2006 | EP1674094A1 Composition containing retinoic acid nanoparticles coated with polyvalent metal inorganic salt |
| 06/28/2006 | EP1673987A1 Temporally meal menu for infants |
| 06/28/2006 | EP1673338A1 Fatty acid compounds, preparation and uses thereof |
| 06/28/2006 | EP1673077A1 Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production |
| 06/28/2006 | EP1673058A1 Composition and method for promoting hair growth |
| 06/28/2006 | EP1409034B1 Topical pharmaceutical formulation |
| 06/28/2006 | EP1404327B1 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1229894B8 Cosmetic compositions containing chick pea extract and retinoids |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP1073439B1 Pharmaceutical composition |
| 06/28/2006 | EP1062237B1 Ribonucleotide polypeptides containing metal |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | CN1795195A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795008A Histamine binding compounds for treatment method for disease conditions mediated by neutrophils. |
| 06/28/2006 | CN1795006A Hair regrowth agent |
| 06/28/2006 | CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof |
| 06/28/2006 | CN1794988A Method for treating vascular hyperpermeable disease |
| 06/28/2006 | CN1794983A Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 06/28/2006 | CN1794915A Aqueous compositions for disinfection and/or sterilization |
| 06/28/2006 | CN1792368A Medicine for treating burns or scald, and its preparing method |
| 06/28/2006 | CN1261164C Medicine for burn and scald and its preparation |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/28/2006 | CN1261140C Medicine for treating burns and scalds |
| 06/28/2006 | CN1261132C Traditional Chinese medicine preparation for treating children dermatosis and its preparation method |
| 06/28/2006 | CN1261130C Medicine for dispelling tinea |
| 06/28/2006 | CN1261128C Medicine for treating burn and scald, preparing method thereof |
| 06/28/2006 | CN1261123C Chinese medicine preparation for treating pasteur cystic, furuncle, furunculosis and carbuncle |
| 06/28/2006 | CN1261117C Medicine for treating bum, empyrosis and bedsore |
| 06/28/2006 | CN1261112C Medicine for treating psoriasis and its preparation method |
| 06/28/2006 | CN1261107C Chinese medicine for treating eczema and dermatitis |
| 06/28/2006 | CN1261106C Externally applied liquor for treating psoriasis and preparation method |
| 06/28/2006 | CN1261104C Glossy-ganoderma-spore polysaccharide for injection and its preparation process |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261091C Compound aloe cream for eliminating pox and cicatrice |
| 06/28/2006 | CN1261090C Acidic composition for external use and agent for accelerating infiltration of cosmetic preparation, hair-growing agent, and preparation for external use each containing the composition into skin |
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |